Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GLI3 mRNA | decreases expression | 19150397 20382639
|
D004958 |
Estradiol |
Estradiol results in decreased expression of GLI3 mRNA | decreases expression | 15328011
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of GLI3 gene | increases mutagenesis | 18397875
|
D014635 |
Valproic Acid |
GLI3 gene mutant form results in increased susceptibility to Valproic Acid | increases response to substance | 16359493
|
D014635 |
Valproic Acid |
GLI3 protein results in decreased susceptibility to Valproic Acid | decreases response to substance | 16359493
|
D014635 |
Valproic Acid |
Valproic Acid promotes the reaction [GLI3 gene mutant form affects the expression of FGF8 mRNA] | affects expression|increases reaction | 16359493
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.11 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.35 | 19490988 |
MESH:D055673 |
Acrocallosal Syndrome |
marker/mechanism |
|
| |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.17 | 11473722 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.92 | 6695378 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.96 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.90 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.98 | 19460635 20603192 17688650 17507914 18940202 18316065 18177632 16609825 19232924 15238991 18396377 18558336 17157402 18775368 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.24 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.63 | 8888407 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
5.28 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.68 | 18412241 15144691 16357521 16651633 16436596 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.10 | 16675129 12948864 14630087 17289903 17261762 18497071 17018787 19861407 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.09 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.79 | 16924424 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.86 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
12.86 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
12.86 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.71 | 17160924 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.82 | 20734317 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.91 | 8888407 17688650 16575769 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.78 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.25 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.51 | 1851702 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.71 | 18357618 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.22 | 18566989 11473722 19148513 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.71 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.64 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.11 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.96 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.86 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.69 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.15 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.72 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.61 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.64 | 8888407 18558336 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
4.07 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.62 | 18412241 16651633 16357521 |
MESH:C537300 |
Greig cephalopolysyndactyly syndrome |
marker/mechanism |
|
| 10441342 9302279 14608643 15739154 18154020 18241058 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.76 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.47 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.50 | 17688650 |
MESH:D017496 |
Hypopigmentation |
marker/mechanism |
|
| 18397875 |
MESH:C537158 |
Hypothalamic hamartomas |
marker/mechanism |
|
| |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.21 | 16627594 16393666 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.78 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
8.88 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
8.88 | 17379185 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.20 | 16294345 17596541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.68 | 14716833 14659978 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.98 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
2.63 | 6695378 16019985 17703301 16271038 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
4.22 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.61 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
7.10 | 17203775 16891317 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
7.10 | 18041768 10767621 10838139 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.21 | 19453300 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.71 | 17943659 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.47 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.45 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.35 | 17596541 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.59 | 16810080 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.96 | 16707424 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.36 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.16 | 16427766 11399458 |
MESH:D009436 |
Neural Tube Defects |
marker/mechanism |
|
| 16359493 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.37 | 16359493 8888407 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
6.05 | 17160924 16003739 16651423 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.71 | 17160924 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.31 | 19401270 |
MESH:D054975 |
Pallister-Hall Syndrome |
marker/mechanism |
|
| 15739154 21532573 |
OMIM:174200 |
POLYDACTYLY, POSTAXIAL, TYPE A1 |
marker/mechanism |
|
| |
OMIM:174700 |
POLYDACTYLY, PREAXIAL IV |
marker/mechanism |
|
| |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.46 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.31 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.02 | 16740699 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.26 | 12752131 11422049 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.64 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.99 | 16876388 15475178 14763951 3137016 11044598 17978042 1511512 11738929 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.09 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.26 | 12833885 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.79 | 15790496 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.41 | 19048282 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.96 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.15 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.20 | 8888407 |